Sana Biotechnology, Inc. (SANA) Financial Statements (2026 and earlier)

Company Profile

Business Address 188 EAST BLAINE STREET, SUITE 350
SEATTLE, WA
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments138,382,000152,497,000205,195,000423,963,000550,996,000
Cash and cash equivalent71,870,000127,566,000133,517,000176,765,000253,029,000
Short-term investments66,512,00024,931,00071,678,000247,198,000297,967,000
Restricted cash and investments4,195,0003,832,0003,832,0006,100,000 
Other undisclosed current assets6,099,0004,479,0004,488,00014,374,0007,105,000
Total current assets:148,676,000160,808,000213,515,000444,437,000558,101,000
Noncurrent Assets
Operating lease, right-of-use asset38,313,00057,961,00074,903,00092,486,00096,320,000
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization26,906,00077,308,00070,689,00066,917,00065,464,000
Long-term investments and receivables    10,051,000195,881,000
Long-term investments    10,051,000195,881,000
Intangible asset, including goodwill, after accumulated amortization199,822,000199,822,000199,822,000199,822,000199,822,000
Goodwill140,627,000140,627,000140,627,000140,627,000140,627,000
Intangible asset, excluding goodwill, after accumulated amortization59,195,00059,195,00059,195,00059,195,00059,195,000
Restricted cash and investments    4,408,0008,819,000
Other noncurrent assets3,173,0005,121,0006,370,0004,599,0005,000,000
Total noncurrent assets:268,214,000340,212,000351,784,000378,283,000571,306,000
TOTAL ASSETS:416,890,000501,020,000565,299,000822,720,0001,129,407,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18,209,00022,406,00031,982,00033,243,00027,709,000
Employee-related liabilities✕✕✕✕✕21,131,000
Accounts payable1,669,0005,210,0004,108,0002,857,0002,219,000
Accrued liabilities16,540,00017,196,00027,874,00030,386,0004,359,000
Business combination, contingent consideration, liability40,200,000  55,345,00051,382,000
Other undisclosed current liabilities20,317,00023,027,00032,505,00022,916,00020,144,000
Total current liabilities:78,726,00045,433,00064,487,000111,504,00099,235,000
Noncurrent Liabilities
Long-term debt and lease obligation:     101,784,000
Liabilities, other than long-term debt158,042,000200,527,000200,507,000190,894,000102,361,000
Other liabilities10,600,0009,896,000   
Operating lease, liability63,924,00081,663,00090,901,00095,860,000101,784,000
Business combination, contingent consideration, liability83,518,000108,968,000109,606,00095,034,000102,361,000
Other undisclosed noncurrent liabilities19,238,0004,556,00012,799,00021,007,00097,525,000
Total noncurrent liabilities:177,280,000205,083,000213,306,000211,901,000301,670,000
Total liabilities:256,006,000250,516,000277,793,000323,405,000400,905,000
Equity
Equity, attributable to parent160,884,000250,504,000287,506,000499,315,000728,502,000
Common stock27,00022,00020,00019,00018,000
Additional paid in capital2,009,845,0001,855,318,0001,625,637,0001,558,459,0001,515,210,000
Accumulated other comprehensive income (loss)28,00014,000(60,000)(4,327,000)(1,366,000)
Accumulated deficit(1,849,016,000)(1,604,850,000)(1,338,091,000)(1,054,836,000)(785,360,000)
Total equity:160,884,000250,504,000287,506,000499,315,000728,502,000
TOTAL LIABILITIES AND EQUITY:416,890,000501,020,000565,299,000822,720,0001,129,407,000

Income Statement (P&L) (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating expenses(250,319,000)(272,723,000)(293,141,000)(272,564,000)(356,909,000)
Operating loss:(250,319,000)(272,723,000)(293,141,000)(272,564,000)(356,909,000)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))		2,305,000(4,507,000)(52,000)(674,000)305,000
Loss from continuing operations before equity method investments, income taxes:(248,014,000)(277,230,000)(293,193,000)(273,238,000)(356,604,000)
Other undisclosed income from continuing operations before income taxes     676,000
Loss from continuing operations:(248,014,000)(277,230,000)(293,193,000)(273,238,000)(355,928,000)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(355,928,000)
Other undisclosed net income3,848,00010,471,0009,938,0003,762,000 
Net loss:(244,166,000)(266,759,000)(283,255,000)(269,476,000)(355,928,000)
Other undisclosed net income attributable to parent     
Net loss available to common stockholders, diluted:(244,166,000)(266,759,000)(283,255,000)(269,476,000)(355,928,000)

Comprehensive Income (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(244,166,000)(266,759,000)(283,255,000)(269,476,000)(355,928,000)
Comprehensive loss:(244,166,000)(266,759,000)(283,255,000)(269,476,000)(355,928,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent14,00074,0004,267,000(2,961,000)(1,396,000)
Comprehensive loss, net of tax, attributable to parent:(244,152,000)(266,685,000)(278,988,000)(272,437,000)(357,324,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: